Riskpilot← Back to searchSign inGet full accessQ-THERA AS
ASActiveOrg 912715043Fjordgata 50, 7010 TrondheimEconomic activity was not specified by tax authority · NACE 0000Est. 20130 employees
Revenue 2024
NOK 0
EBITDA margin
—
-48% vs 2023
Equity ratio
96.1%
Financial strength
Net profit 2024
NOK 9,2M
+2439% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -586K | -48% |
| Net profit | NOK 9,2M | +2439% |
| Total assets | NOK 19,4M | +87% |
| Equity | NOK 18,7M | +98% |
| Employees | 0 | — |
Legal name
Q-THERA AS
Org number
912715043
Legal form
Aksjeselskap
NACE code
0000 · Economic activity was not specified by tax authority
Founded
11. november 2013
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Investering i aksjer, andeler og fast eiendom. I tillegg skal selskapet kunne drive kjøp og salg av hudpleieprodukter, laserutstyr samt rådgivning og andre tjenester som står i forbindelse med dette.
Address
Fjordgata 50, 7010 Trondheim
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −2 949 | −47 | −62 | −395 | −586 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −2 949 | −47 | −62 | −395 | −586 |
| Net financials | 3 297 | 4 946 | 4 950 | 0 | 9 831 |
| Profit before tax | 348 | 4 899 | 4 888 | −395 | 9 245 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 348 | 4 899 | 4 888 | −395 | 9 245 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 491 | 5 444 | 10 367 | 10 370 | 19 407 |
| Equity | 14 | 4 914 | 9 802 | 9 406 | 18 652 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 476 | 530 | 565 | 963 | 755 |
| Total debt | 476 | 530 | 565 | 963 | 755 |
EBITDA margin
-58555300.0%
This company
15.8%
Market median
-370603265% vs market
20202024
Equity ratio
96.1%
This company
38.2%
Market median
+152% vs market
20202024
Return on equity
49.6%
This company
18.4%
Market median
+170% vs market
20202024
Net profit margin
924547500.0%
This company
8.1%
Market median
+11414166567% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KM Contact Person | Contact Person | 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2023 | |
| Former (1) | ||
| Chairman | 2016 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
OSLO HUDKLINIKK AS
Q-THERA AS Board members of Q-THERA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristian Meling Nygård | Contact Person | 0 companies |
| Ole Martin Rørdam | Chairman | 0 companies |
| Jean-Marie Bettinger | Chairman | 0 companies |